SOLV Solventum Corp.

$79.51

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 11/21/2025

About Solventum Corp.

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. The company is headquartered in Saint Paul, Minnesota.

Website: https://www.solventum.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1964738
Address
3M CENTER, BUILDING 275-6W, 2510 CONWAY AVENUE EAST, MAPLEWOOD, MN, UNITED STATES
Valuation
Market Cap
$11.46B
P/E Ratio
24.01
PEG Ratio
nan
Price to Book
3.87
Performance
EPS
$2.76
Dividend Yield
—
Profit Margin
5.80%
ROE
6.55%
Technicals
50D MA
$73.89
200D MA
$68.15
52W High
$85.92
52W Low
$47.16
Fundamentals
Shares Outstanding
173M
Target Price
$80.89
Beta
nan

SOLV EPS Estimates vs Actual

● Estimated
● Actual

SOLV News & Sentiment

Nov 13, 2025 • Zacks Commentary BULLISH
BDX Unveils Portable PureWick System for On-the-Go Incontinence Care
BD expands its PureWick line with a portable system built for discreet, mobile incontinence care, aiming to deepen its home-care reach.
Nov 13, 2025 • Zacks Commentary SOMEWHAT-BULLISH
STXS Secures FDA Approval for GenesisX to Broaden Surgical Robotics
Stereotaxis wins FDA clearance for GenesisX, a streamlined robotic system aimed at boosting hospital adoption and accelerating growth.
Nov 12, 2025 • Zacks Commentary BULLISH
SOLV vs. DHR: Which Stock Is the Better Value Option?
Investors interested in Medical Services stocks are likely familiar with Solventum ( SOLV Quick QuoteSOLV - ) and Danaher ( DHR Quick QuoteDHR - ) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.
Nov 11, 2025 • Zacks Commentary BULLISH
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now
DXCM's strong Q3 growth, expanding CGM coverage and innovation-driven momentum position it for sustained adoption despite rising competition.
Nov 11, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Solventum ( SOLV ) Upgraded to Strong Buy: What Does It Mean for the Stock?
Solventum (SOLV) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Nov 10, 2025 • Zacks Commentary BULLISH
SOLV or DHR: Which Is the Better Value Stock Right Now?
SOLV vs. DHR: Which Stock Is the Better Value Option?
Sentiment Snapshot

Average Sentiment Score:

0.365
50 articles with scored sentiment

Overall Sentiment:

Bullish

SOLV Reported Earnings

Aug 07, 2025
Jun 30, 2025 (Pre market)
0.01 Surprise
  • Reported EPS: $1.69
  • Estimate: $1.68
  • Whisper: —
  • Surprise %: 0.6%
May 08, 2025
Mar 31, 2025 (Pre market)
-0.79 Surprise
  • Reported EPS: $0.78
  • Estimate: $1.57
  • Whisper: —
  • Surprise %: -50.3%
Feb 27, 2025
Dec 31, 2024 (Pre market)
-0.09 Surprise
  • Reported EPS: $1.41
  • Estimate: $1.50
  • Whisper: —
  • Surprise %: -6.0%
Nov 07, 2024
Sep 30, 2024 (Pre market)
0.1 Surprise
  • Reported EPS: $1.64
  • Estimate: $1.54
  • Whisper: —
  • Surprise %: 6.5%
Aug 08, 2024
Jun 30, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $1.56
  • Estimate: $1.51
  • Whisper: —
  • Surprise %: 3.3%
May 09, 2024
Mar 31, 2024 (Pre market)
0.33 Surprise
  • Reported EPS: $2.08
  • Estimate: $1.75
  • Whisper: —
  • Surprise %: 18.9%
Feb 28, 2024
Dec 31, 2023 (Pre market)
2.31 Surprise
  • Reported EPS: $2.31
  • Estimate: $0.00
  • Whisper: —
  • Surprise %: 0.0%

Financials